- Udyam number
- UDYAM-PB-17-0006788

About Banson Pharmaceuticals Private Limited
Data last updated:
Banson Pharmaceuticals Private Limited is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1995PTC016354. Its GSTIN is 03AAACB7134R1ZJ (Punjab).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Santosh Kumar Bansal and Anish Kumar Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # Dewana Streetnabha Distt Patiala, Punjab, India – 147201.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.3 Cr, a growth of 92% compared to the previous year. For the same year it recorded a net profit of ₹6.58 Lakh (net margin 0.6%) and EBITDA of ₹71.59 Lakh (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 19% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Banson Pharmaceuticals Pvt Ltd. As per MCA filings, the company has open charges of ₹9.08 Cr and satisfied charges of ₹15.33 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 1 case is pending.
Banson Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PB-17-0006788). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bansonpharma.com.
Company details
Recognitions & Rankings of Banson Pharmaceuticals
Contact details
Banson Pharmaceuticals Private Limited's registered office is in Punjab. Its website is bansonpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address# Dewana Streetnabha Distt Patiala, Punjab, India – 147201
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Banson Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Banson Pharmaceuticals operates one associated brand: Banson Pharmaceuticals Pvt Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of high-quality pharmaceutical tablets, capsules, and formulations in India. | bansonpharma.com |
Business activity
The main business activity of Banson Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Banson Pharmaceuticals Private Limited, buy the company report.
Financials of Banson Pharmaceuticals Private Limited
FY 2025 filings availableBanson Pharmaceuticals Private Limited reported revenue of ₹10.3 Cr (up 92% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 92% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹71.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Banson Pharmaceuticals Private Limited, buy the company report.
Board of directors of Banson Pharmaceuticals Private Limited
Banson Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Bansal Also directs: Andes Healthcare Private Limited | Director | 05 May 1995 | 31 Years 6 Months | Current |
| Anish Kumar Bansal Also directs: Andes Healthcare Private Limited | Director | 02 Apr 2022 | 4 Years 7 Months | Current |
Peer comparison
Banson Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oasis Pharma and Phytomolecules Private Limited | ₹10.36 Cr (FY 2025) | 48.0% | Chandigarh, India | |||
| Essenzaa Nutrition Private Limited | ₹10.33 Cr (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Banson Pharmaceuticals Private Limitedthis company | ₹10.3 Cr (FY 2024) | ₹6.58 Lakh | 0.6% | 92.0% | 2 | Punjab, India |
| Oziel Pharmaceuticals Private Limited | ₹10.29 Cr (FY 2025) | 14.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Banson Pharmaceuticals Private Limited, buy the company report.
Auditor
Banson Pharmaceuticals Private Limited is audited by B.S.GOYAL & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B.S.GOYAL & CO | FY 2022 | 005076N |
Shareholding
The shareholding of Banson Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Banson Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 2025 | 101167333 | Canara Bank | ₹1 Cr | Open | |
| 18 Sep 2025 | 101167336 | Canara Bank | ₹9.01 Lakh | Open | |
| 18 Sep 2025 | 101167348 | Canara Bank | ₹19.4 Lakh | Open | |
| 18 Sep 2025 | 101167356 | Canara Bank | ₹6.75 Cr | Open | |
| 18 Sep 2025 | 101167617 | Canara Bank | ₹1.01 Cr | Open |
To see the full charge records of Banson Pharmaceuticals Private Limited, buy the company report.
Total charge records: 18 View all charges
Legal cases
Banson Pharmaceuticals Private Limited has 20 court cases on record: 7 filed by Banson Pharmaceuticals, 13 filed against it. 1 case is pending and 19 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 11 | 0 |
| High courts | 7 | 2 | 1 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Hab Pharmaceuticals and Research Ltd. and Anr. | Pending |
| District court, Central, Delhi | Criminal case | Filed against the company by Indo Pack Ltd | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Hab Pharmaceuticals and Research Ltd. and Anr. | Disposed |
| District court, Central, Delhi | Civil suit | Filed against the company by Ms Wings Pharmaceuticals Pvt. Ltd. | Disposed |
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by M/S Choice Medicines Traders | Disposed |
To see the full case history of Banson Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Banson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Banson Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of May 2026.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 2 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Banson Pharmaceuticals Private Limited, buy the company report.
GST
Banson Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAACB7134R1ZJ | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Banson Pharmaceuticals Private Limited, buy the company report.
Recent activity
Banson Pharmaceuticals Private Limited has 8 board changes on record since 1995: 5 appointments and 3 cessations. The latest: Anish Kumar Bansal was appointed as Director on 02 Apr 2022.
32 earlier events are in the company report.
Frequently asked questions
Banson Pharmaceuticals is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 1995 (31+ years old) and is registered under CIN U24232PB1995PTC016354.
Banson Pharmaceuticals has 2 current directors:
- Santosh Kumar Bansal - Director
- Anish Kumar Bansal - Director
The latest financial statements of Banson Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Banson Pharmaceuticals is 03AAACB7134R1ZJ, registered in Punjab.
The CIN (Corporate Identification Number) of Banson Pharmaceuticals is U24232PB1995PTC016354. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Banson Pharmaceuticals has 20 court cases on record: 7 filed by the company and 13 filed against it. 1 is pending. Most are in the district courts.
Banson Pharmaceuticals was incorporated on 05 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Banson Pharmaceuticals by revenue are Oasis Pharma and Phytomolecules Private Limited, Essenzaa Nutrition Private Limited, Oziel Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anish Kumar Bansal was appointed as Director on 02 Apr 2022. Kiran Bansal ceased to be Director on 02 Apr 2022. Rajesh Kumar Bansal ceased to be Director on 06 Jun 2009. Banson Pharmaceuticals has 8 board changes on record in total.
Yes, Banson Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-PB-17-0006788).
Banson Pharmaceuticals can be reached through the website bansonpharma.com. Its registered office is in Punjab, India.

